Silo Pharma (SILO) Receivables - Accured (2013 - 2023)
Silo Pharma (SILO) posted Receivables - Accured of $9600.0 for Q3 2023, up 14.42% sequentially from $8390.0 in Q2 2023, and up 100.0% YoY from $4800.0 in Q3 2022.
Silo Pharma (SILO) Receivables - Accured (2013 - 2023) Analysis & Trends
Silo Pharma has reported Receivables - Accured for 5 years, with the latest figure at $9600.0 in Q3 2023.
- Quarterly Receivables - Accured rose 100.0% year-over-year to $9600.0 in Q3 2023, while the trailing twelve-month figure through Sep 2023 was $9600.0 (up 100.0% YoY) and the FY2022 annual result came in at $6010.0, down 2.44% from the prior year.
- Receivables - Accured advanced to $9600.0 in Q3 2023 per SILO's latest filing, from $8390.0 in the prior quarter.
- Over five years, Receivables - Accured peaked at $27876.0 in Q4 2020 and troughed at $2394.0 in Q1 2022.
- A 4-year average of $8445.9 and a median of $6160.0 in 2021 frame the typical range for Receivables - Accured.
- The sharpest annual moves came in 2021 and 2023: Receivables - Accured slumped 77.9% in 2021, then jumped 200.46% in 2023.
- Over 4 years, Receivables - Accured stood at $27876.0 in 2020, then plunged by 77.9% to $6160.0 in 2021, then declined by 2.44% to $6010.0 in 2022, then jumped by 59.73% to $9600.0 in 2023.
- According to Business Quant data, Receivables - Accured over the past three periods registered $9600.0, $8390.0, and $7193.0 for Q3 2023, Q2 2023, and Q1 2023 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables - Accured (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.65 Bn | 130.80 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.93 Bn | 77.94 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.84 Bn | 59.66 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.38 Bn | 52.25 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.94 Bn | 36.84 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.54 Bn | 28.23 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 27.72 Bn | 9.33 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.49 Bn | 26.33 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - | - |
| 10 | Silo Pharma | 2.96 Mn | 2.96 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 9,600.00 |
| Sep 30, 2023 | 9,600.00 |
| Jun 30, 2023 | 8,390.00 |
| Jun 30, 2023 | 8,390.00 |
| Mar 31, 2023 | 7,193.00 |
| Mar 31, 2023 | 7,193.00 |
| Dec 31, 2022 | 6,010.00 |
| Dec 31, 2022 | 6,010.00 |
| Sep 30, 2022 | 4,800.00 |
| Sep 30, 2022 | 4,800.00 |
| Jun 30, 2022 | 3,590.00 |
| Jun 30, 2022 | 3,590.00 |
| Mar 31, 2022 | 2,394.00 |
| Mar 31, 2022 | 2,394.00 |
| Dec 31, 2021 | 6,160.00 |
| Dec 31, 2021 | 6,160.00 |
| Dec 31, 2020 | 27,876.00 |
| Dec 31, 2020 | 27,876.00 |
| Dec 31, 2013 | 600.00 |
| Dec 31, 2013 | 600.00 |